L. Tenelbayeva
Research Subjects
L. Tenelbayeva has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Céline Cakir-Kiefer
INRAE, URAFPA, Université de Lorraine, F-54000 Nancy, France
1 shared publication - E. D. Dzhangalina
Institute of Genetic and Physiology, Al-Farabi 93, Almaty 050040, Kazakhstan
1 shared publication - Gulminyam Baratzhanova
Université de Lorraine, INRAE, L2A, Nancy F-54000, France; al Farabi Kazakh National University, Faculty of Biology and Biotechnology, Almaty 050040, Kazakhstan; Institute of General Genetics and Physiology, Almaty 050060, Kazakhstan
1 shared publication - Gulshat Koishekenova
Institute of Genetics and Physiology, Department of experimental mutagenesis, Almaty, Kazakhstan
1 shared publication - Leyla Djansugurova
RSE “Institute of Genetics and Physiology” of the Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan, 93 Al-Farabi Avenue, Almaty 050060, Kazakhstan
1 shared publication - N. P. Kabysheva
M. Aikimbaev’s Kazakh Scientific Centre for Quarantine and Zoonotic Diseases
1 shared publication
Latest Publications
- Open Access
- 30 June 2026
- Published by al-Farabi Kazakh National University in International Journal of Biology and Chemistry
- Vol. 19 (1)
The advantages and limitations of human liver models in in vitro toxicology study
This review collects and analyses information about modern liver models used in toxicological studies from 2015 to January 2026. Currently, human liver models are increasingly being improved and various approaches being explored, including the selection of different cell types and advanced cultivation methods, to more accurately simulate the in vivo liver environment to replace animal models. These new methods are increasing the complexity of in vitro systems. However, the complex liver models currently available are not yet a complete replacement for animal models and does not have all the characteristics of the liver. Since many models undergo phenotypic changes during prolonged cultivation, this limits their suitability for long-term studies of repeated administration toxicity. Moreover, they have limited suitability, lack of vascularization, labour demanding and expensive. However, compared to early 2D hepatocyte cultures, these modern systems demonstrate significantly improved prediction accuracy and physiological relevance. With continued development, it may be possible to create models capable of tracking the occurrence, progression, and potential reversibility of liver drug toxicity. Key words: liver cells, HepG2, HepaRG, 2D culture, 3D culture, toxicology
- 30 June 2026
- Published by al-Farabi Kazakh National University in International Journal of Biology and Chemistry
- Vol. 19 (1)
Open AccessThe advantages and limitations of human liver models in in vitro toxicology study
This review collects and analyses information about modern liver models used in toxicological studies from 2015 to January 2026. Currently, human liver models are increasingly being improved and various approaches being explored, including the selection of different cell types and advanced cultivation methods, to more accurately simulate the in vivo liver environment to replace animal models. These new methods are increasing the complexity of in vitro systems. However, the complex liver models currently available are not yet a complete replacement for animal models and does not have all the characteristics of the liver. Since many models undergo phenotypic changes during prolonged cultivation, this limits their suitability for long-term studies of repeated administration toxicity. Moreover, they have limited suitability, lack of vascularization, labour demanding and expensive. However, compared to early 2D hepatocyte cultures, these modern systems demonstrate significantly improved prediction accuracy and physiological relevance. With continued development, it may be possible to create models capable of tracking the occurrence, progression, and potential reversibility of liver drug toxicity. Key words: liver cells, HepG2, HepaRG, 2D culture, 3D culture, toxicology